Plasma Vincristine Levels Are 100-Fold Higher with Marqibo® (Vincristine Sulfate LIPOSOME Injection) in Place of Standard Vincristine in Combination Chemotherapy of Patients ≥ 60 Years Old with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Roswell Park Comprehensive Cancer Center, University of California, Los Angeles, Emory University, Winship Cancer Institute, University of Chicago Medical Center, Duke University, Duke Cancer Institute, Weill Cornell Medicine, Washington University in St. Louis, University of California San Diego, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Spectrum Pharmaceuticals (United States), Hackensack University Medical Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980305338